Organisation paid for research Program year 2025 Source: CMS Open Payments

Apex Trials Group, LLC

Neither a doctor nor a teaching hospital

Research payments

$80,228

28 payments

Through program year 2025, Apex Trials Group, LLC is reported as receiving $80,228 in research payments, across 28 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2025	Research	$1,512	1
2023	Research	$78,716	27

Breakdown

Who paid Research payments · program years 2023–2025

Argenx US, Inc. $80,228 28 payments

Studies the money was for Research payments · program years 2023–2025

A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and the Safety of Efgartigimod (ARGX-113) PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia $37,087 6 payments
Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS $28,792 17 payments
Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of Efgartigimod in Adult Patients With Post-COVID-19 Postural Orthostatic Tachycardia Syndrome (PC-POTS) Who Completed Study ARGX-113-2104 $12,837 4 payments
Quincy Model - Open-Label Extension Study to Evaluate the Long term Safety and Efficacy of Efgartigimod in Adult Patients with Post-COVID-19 Postural Orthostatic Tachycardia Syndrome (PC-POTS) who Completed Study ARGX 113-2104 $1,512 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.